Skip to main content
NCD 230.18 · version 1

NCD 230.18: Sacral Nerve Stimulation For Urinary Incontinence

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 230.18

Benefit category
Prosthetic Devices
Effective date
01/01/2002
Implemented 01/01/2002
Transmittal
Transmittal 144
Versions published
1
Manual section
230
Renal and Genitourinary System - ESRD Services, NCD Manual (Pub. 100-03) chapter 1 part 4

TL;DR

NCD 230.18 sets Medicare's national policy for sacral nerve stimulation for urinary incontinence under the benefit category "Prosthetic Devices", effective 01/01/2002 and implemented 01/01/2002. Effective January 1, 2002, sacral nerve stimulation is covered for the treatment of urinary urge incontinence, urgency-frequency syndrome, and urinary retention. Sacral nerve stimulation involves both a temporary test stimulation to determine if… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

Effective January 1, 2002, sacral nerve stimulation is covered for the treatment of urinary urge incontinence, urgency-frequency syndrome, and urinary retention. Sacral nerve stimulation involves both a temporary test stimulation to determine if an implantable stimulator would be effective and a permanent implantation in appropriate candidates. Both the test and the permanent implantation are covered.

The following limitations for coverage apply to all three indications:

• Patient must be refractory to conventional therapy (documented behavioral, pharmacologic and/or surgical corrective therapy) and be an appropriate surgical candidate such that implantation with anesthesia can occur.

• Patients with stress incontinence, urinary obstruction, and specific neurologic diseases (e.g., diabetes with peripheral nerve involvement) which are associated with secondary manifestations of the above three indications are excluded.

• Patient must have had a successful test stimulation in order to support subsequent implantation. Before a patient is eligible for permanent implantation, he/she must demonstrate a 50% or greater improvement through test stimulation. Improvement is measured through voiding diaries.

• Patient must be able to demonstrate adequate ability to record voiding diary data such that clinical results of the implant procedure can be properly evaluated.

Text reproduced from the CMS Medicare Coverage Database record for NCD 230.18 version 1. View the original on cms.gov.

Local policies that build on this NCD

3 active Local Coverage Determinations cite NCD 230.18 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 230.18

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 5 current articles in the Medicare Coverage Database name NCD 230.18, 5 of them with a covered ICD-10-CM list, from 4 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

A53359: Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence

Billing and Coding, effective 2026-04-06 · Noridian Healthcare Solutions, LLC (01111, 01112, 01182, 01211, 01212, 01311, 01312, 01911, 02101, 02102, 02201, 02202, 02301, 02302, 02401, 02402, 03101, 03102, 03201, 03202, 03301, 03302, 03401, 03402, 03501, 03502, 03601, 03602) · CMS record

40 covered ICD-10-CM codes; 19 procedure codes: 0786T, 0787T, 0788T, 0789T, 64561, 64581, 64585, 64590, 64595, 64596, 64597, 64598 and 7 more. Check a diagnosis for 0786T.

First covered codes: N30.10 Interstitial cystitis (chronic) without hematuria; N30.11 Interstitial cystitis (chronic) with hematuria; N36.44 Muscular disorders of urethra; N39.41 Urge incontinence; N39.42 Incontinence without sensory awareness; N39.46 Mixed incontinence; …

A55835: Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence

Billing and Coding, effective 2026-03-05 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record

20 covered ICD-10-CM codes; 9 procedure codes: 64561, 64581, 64590, A4290, C1767, C1778, C1883, C1897, L8680. Check a diagnosis for 64561.

First covered codes: N30.10 Interstitial cystitis (chronic) without hematuria; N30.11 Interstitial cystitis (chronic) with hematuria; N36.44 Muscular disorders of urethra; N39.41 Urge incontinence; N39.42 Incontinence without sensory awareness; N39.46 Mixed incontinence; …

A57311: Billing and Coding: Physical Therapy - Home Health

Billing and Coding, effective 2026-08-06 · CGS Administrators, LLC (15004) · CMS record

14,836 covered ICD-10-CM codes; 50 procedure codes: 95851, 95852, 97010, 97012, 97016, 97018, 97022, 97024, 97026, 97028, 97032, 97033 and 38 more. Local policy: L33942 Physical Therapy - Home Health. Check a diagnosis for 95851.

First covered codes: B91 Sequelae of poliomyelitis; E08.44 Diabetes mellitus due to underlying condition with diabetic amyotrophy; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; E09.44 Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy; E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene; E10.44 Type 1 diabetes mellitus with diabetic amyotrophy; …

A57453: Billing and Coding: Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

4 covered ICD-10-CM codes; 1 procedure code: 64566. Local policy: L33396 Posterior Tibial Nerve Stimulation for Voiding Dysfunction. Check a diagnosis for 64566.

First covered codes: N32.81 Overactive bladder; N39.41 Urge incontinence; R35.0 Frequency of micturition; R39.15 Urgency of urination.

A57595: Billing and Coding: Pelvic Floor Dysfunction: Anorectal Manometry and EMG

Billing and Coding, effective 2026-03-05 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

134 covered ICD-10-CM codes in 2 groups; 3 procedure codes: 51784, 51785, 91125. Local policy: L35486 Pelvic Floor Dysfunction: Anorectal Manometry and EMG. Check a diagnosis for 51784.

First covered codes: G04.1 Tropical spastic paraplegia; G35.A Relapsing-remitting multiple sclerosis; G35.B0 Primary progressive multiple sclerosis, unspecified; G35.B1 Active primary progressive multiple sclerosis; G35.B2 Non-active primary progressive multiple sclerosis; G35.C0 Secondary progressive multiple sclerosis, unspecified; …

Coverage analysis history

CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links one analysis to NCD 230.18, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.

  1. CAG-00058N Sacral Nerve Stimulation for Urge Urinary Incontinence (New, Closed)

Revision history

12/2025 - The purpose of the Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations(NCDs). No policy is being changed as a result of these updates. ( TN 13455 ) (CR14263)

10/2024 - The purpose of the Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations(NCDs). No policy is being changed as a result of these updates. ( TN 12904 ) (CR13828)

02/2024 - The purpose of this Change Request (CR) is to provide a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. ( TN 12493 ) (CR13507)

02/2020 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.

Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, longstanding NCD process. ( TN 2439 ) (CR11655)

11/2018 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.

Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process.( TN 2202 ) (CR11005)

11/2016 - This change request (CR) is the 9th maintenance update of ICD-10 conversions and other coding updates specific to national coverage determinations (NCDs). The majority of the NCDs included are a result of feedback received from previous ICD-10 NCD CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, CR9540, and CR9631. Some are the result of revisions required to other NCD-related CRs released separately.

Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent, quarterly releases as needed. No policy-related changes are included with these updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process. ( TN 1753 ) (CR9751)

08/2016 - This change request (CR) is the 9th maintenance update of ICD-10 conversions and other coding updates specific to national coverage determinations (NCDs). The majority of the NCDs included are a result of feedback received from previous ICD-10 NCD CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, CR9540, and CR9631. Some are the result of revisions required to other NCD-related CRs released separately.

Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent, quarterly releases as needed. No policy-related changes are included with these updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process. ( TN 1708 ) (CR9751)

04/2016 - Transmittal 1630, dated February 26, 2016, is being rescinded and replaced by Transmittal 1658 to (1) remove duplicate spreadsheet NCD210.3, (2) add missing spreadsheet NCD20.33, (3) add B/MAC to requirement 3 at request of WPS/B, (4) rename the spreadsheet titles, and, (5) provide a link to the attached spreadsheets for more efficient ease of reference and accessibility. All other information remains the same. ( TN 1658 ) (CR9540)

10/2001 - Added section as result of a national coverage decision. Effective and implementation dates 01/01/2002. ( TN 144 ) (CR 1881)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

Prior authorization in Original Medicare

  • WISeR model prior authorization or pre-payment review in Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington for services on or after January 15, 2026; the model runs through December 31, 2031. CMS service group: Sacral Nerve Stimulation for Urinary Incontinence. Codes on the CMS list: 64561 (with 64590) and 64581. Reviewed only for the ICD-10 indications in Appendix B of the operational guide. 64561: Only when billed with 64590, which marks a permanent implant; trial placement is not reviewed.

Medicare Advantage plans run their own prior authorization lists. See the WISeR services and codes for this NCD.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 230.18

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 230.18

What does NCD 230.18 cover?

Effective January 1, 2002, sacral nerve stimulation is covered for the treatment of urinary urge incontinence, urgency-frequency syndrome, and urinary retention. Sacral nerve stimulation involves both a temporary test stimulation to determine if an implantable stimulator would be effective and a permanent implantation in appropriate candidates. Both the test and the permanent implantation are covered. The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 230.18 take effect?

The current version (1) is effective 01/01/2002, implemented 01/01/2002, published in transmittal 144. This is the only published version.

Does a Local Coverage Determination override NCD 230.18?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.